No Data
Express News | Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Press Release: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Guggenheim Maintains Zentalis Pharmaceuticals(ZNTL.US) With Buy Rating, Cuts Target Price to $8
A Quick Look at Today's Ratings for Zentalis Pharmaceuticals(ZNTL.US), With a Forecast Between $8 to $20
Express News | Zentalis Pharmaceuticals Inc : Guggenheim Cuts Target Price to $8 From $12
Express News | HC Wainwright & Co. Reiterates Buy on Zentalis Pharma, Maintains $20 Price Target
